Exact Mass: 604.3376168

Cerbertin

[(S)-1-Carboxy-2-phenyl-ethyl]-carbamoyl-Arg-Val-Arg-aldehyde

2-[({4-[(diaminomethylidene)amino]-1-{[1-({5-[(diaminomethylidene)amino]-1-oxopentan-2-yl}carbamoyl)-2-methylpropyl]carbamoyl}butyl}carbamoyl)amino]-3-phenylpropanoic acid

C27H44N10O6 (604.3445124)

Dilazep

3-[4-[3-(3,4,5-Trimethoxybenzoyl)oxypropyl]-1,4-diazepan-1-yl]propyl 3,4,5-trimethoxybenzoic acid

C31H44N2O10 (604.2995804)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

Telinavir

N-{4-[(tert-butyl-C-hydroxycarbonimidoyl)(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl}-2-[(quinolin-2-yl)formamido]butanediimidate

C33H44N6O5 (604.3373014)

PA(10:0/18:1(12Z)-O(9S,10R))

[(2R)-3-(decanoyloxy)-2-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]propoxy]phosphonic acid

PA(10:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(12Z)-O(9S,10R)/10:0)

[(2R)-2-(decanoyloxy)-3-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]propoxy]phosphonic acid

PA(18:1(12Z)-O(9S,10R)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-O(9S,10R)/10:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(10:0/18:1(9Z)-O(12,13))

[(2R)-3-(decanoyloxy)-2-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propoxy]phosphonic acid

PA(10:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(9Z)-O(12,13)/10:0)

[(2R)-2-(decanoyloxy)-3-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propoxy]phosphonic acid

PA(18:1(9Z)-O(12,13)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(9Z)-O(12,13)/10:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Antipain

Antipain (dihydrochloride)

C27H44N10O6 (604.3445124)

D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors

aeruginosin 298-A

C30H48N6O7 (604.3584298)

HMR1171

C35H48N4O3S (604.3446938)

Irinotecan carboxylate; CPT-11 carboxylate form

12-Ethyl-8-propylbacteriochlorophyllide d

C35H40MgN4O4+2 (604.28999)

methyl-ent-15alpha-acetoxy-1alpha-(2-methyl-2,3-epoxybutyryloxy)-9alpha-hydroxy-7alpha-isovaleryloxykaur-16-en-19-oate|methyl-ent-15alpha-acetoxy-1alpha-<2-methyl-2,3-epoxybutyryloxy>-9alpha-hydroxy-7alpha-isovaleryloxykaur-16-en-19-oate

methyl-ent-15alpha-acetoxy-1alpha-(2-methyl-2,3-epoxybutyryloxy)-9alpha-hydroxy-7alpha-isovaleryloxykaur-16-en-19-oate|methyl-ent-15alpha-acetoxy-1alpha-<2-methyl-2,3-epoxybutyryloxy>-9alpha-hydroxy-7alpha-isovaleryloxykaur-16-en-19-oate

C33H48O10

taccalonolide O

kalanchoside

(5alpha,7alpha,13alpha17alpha,20S,23R,24R)-21,25-epoxy-23,24-dihydroxy-4,4,8-trimethyl-3-oxocholesta-1,14-dien-7-yl benzeneacetic acid ester|turrapubesol C

16alpha-acetoxy-3-epi-19-norgomphoside 3-acetate

(3R,5aR,5bR,6R,7S,9S,11aS,12R,13bS)-12-(acetyloxy)icosahydro-7,9-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-1H-cyclopenta[a]chrysen-6-yl benzoate|11alpha-(acetyloxy)-7beta-(benzoyloxy)-21alphaH-24-norhopa-4(23),22(29)-diene-3beta,6beta-diol|cavalerol B

(3R,5aR,5bR,6R,7S,9S,11aS,12R,13bS)-12-(acetyloxy)icosahydro-7,9-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-1H-cyclopenta[a]chrysen-6-yl benzoate|11alpha-(acetyloxy)-7beta-(benzoyloxy)-21alphaH-24-norhopa-4(23),22(29)-diene-3beta,6beta-diol|cavalerol B

dichrostachine O

C36H44O8 (604.3036024)

14-acetoxy-3,14-dihydroimplexin

(3R,5aR,5bR,6R,7S,9S,11aR,12S,13bS)-7-(acetyloxy)icosahydro-9,12-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-1H-cyclopenta[a]chrysen-6-yl benzoate|6beta-(acetyloxy)-7beta-(benzoyloxy)-21alphaH-24-norhopa-4(23),22(29)-diene-3beta,11beta-diol|cavalerol G

(3R,5aR,5bR,6R,7S,9S,11aR,12S,13bS)-7-(acetyloxy)icosahydro-9,12-dihydroxy-5a,5b,11a,13b-tetramethyl-8-methylidene-3-(prop-1-en-2-yl)-1H-cyclopenta[a]chrysen-6-yl benzoate|6beta-(acetyloxy)-7beta-(benzoyloxy)-21alphaH-24-norhopa-4(23),22(29)-diene-3beta,11beta-diol|cavalerol G

pedunculol

(1S,2S,3S,4S,4aR,4bR,5aS,6R,6aR,9aR,9bR)-1,2,3,4,4a,4b,5a,6,6a,7,9a,9b-dodecahydro-3,6,6a,9b-tetrahydroxy-5a-(hydroxymethyl)-1,8-dimethyl-3-(1-methylethenyl)-7-oxo-2-(1-oxopropoxy)benz[7,8]azuleno[5,6-b]oxiren-4-yl (2E,4E)-deca-2,4-dienoate|yuanhuaoate C

(1S,2S,3S,4S,4aR,4bR,5aS,6R,6aR,9aR,9bR)-1,2,3,4,4a,4b,5a,6,6a,7,9a,9b-dodecahydro-3,6,6a,9b-tetrahydroxy-5a-(hydroxymethyl)-1,8-dimethyl-3-(1-methylethenyl)-7-oxo-2-(1-oxopropoxy)benz[7,8]azuleno[5,6-b]oxiren-4-yl (2E,4E)-deca-2,4-dienoate|yuanhuaoate C

(1aS,1bR,2aS,3aS,4R,4aS,6S,6aS,7R,8R,11R,12S,13cS)-4,6-bis(acetyloxy)icosahydro-1b,11-dihydroxy-7-(hydroxymethyl)-4a,6a,11,12-tetramethyl-8,12-methanobisoxireno[3,4:6,7]naphtho[2,1:4,5]indeno[1,2-d]oxocin-10(2H)-one|taccalonolide Y

(1aS,1bR,2aS,3aS,4R,4aS,6S,6aS,7R,8R,11R,12S,13cS)-4,6-bis(acetyloxy)icosahydro-1b,11-dihydroxy-7-(hydroxymethyl)-4a,6a,11,12-tetramethyl-8,12-methanobisoxireno[3,4:6,7]naphtho[2,1:4,5]indeno[1,2-d]oxocin-10(2H)-one|taccalonolide Y

16beta-acetoxystrophanthidin-4,6-dideoxy-2,3-methylenedioxy-beta-D-allopyranoside|reevesioside B

Xanthochymol

pelargoside B1

C30H52O12 (604.3458592)

C30H52O12

C30H52O12 (604.3458592)

14beta-hydrogen-(20S,22R)-22,26-epoxy-27-[(beta-glucopyranosyl)oxy]ergosta-2,4,6,24-tetraene-1,26-dione|baimantuoluoside H

cipaferen H

biselyngbyaside

(1R,3S,5S,6aR,7R,8R,9S,10S,10aR*)-1,10-bis(acetyloxy)-5-methoxy-7,8-dimethyl-7-[(2Z)-3-methylpenta-2,4-dien-1-yl]-3,5,6,6a,7,8,9,10-octahydronaphtho[1,8a-c]furan-3,9-diyl dibutanoate

(1R*,3S*,5S*,6aR*,7R*,8R*,9S*,10S*,10aR*)-1,10-bis(acetyloxy)-5-methoxy-7,8-dimethyl-7-[(2Z)-3-methylpenta-2,4-dien-1-yl]-3,5,6,6a,7,8,9,10-octahydronaphtho[1,8a-c]furan-3,9-diyl dibutanoate

(21alpha-H)-24-norneohopa-4(23),22(29)-diene-3beta,6beta,7beta-triol 7-caffeate

caseamembrin R|rel-(2S,5R,6S,7R,8S,9S,10R,18S,19R)-2-(2-methylbutanoyloxy)-18-butanoyloxy-7,19-diacetoxy-18,19-epoxy-6,7-dihydroxy-cleroda-3,13(16),14-triene

stemphone F

11beta-Alcohol, Me ester-Viridominic acid A

16beta-O-acetyl-scillarenin-3-O-beta-D-glucoside|3-O-beta-Glucopyranoside,16-Ac-3,14,16-Trohydroxybufa-4,20,22-trienolide

physagulin

Casearin N

cinobufagin 3-O-beta-D-glucopyranoside|cinobufagin 3-O-beta-D-glucoside

C34H44N4O6 (604.3260683999999)

C30H53BrO7

C30H53BrO7 (604.2974448)

aplysioviolin

cryptophycin 4|Cryptophycin D|cryptophycin-4

C35H44N2O7 (604.3148354)

(5alpha,7alpha,13alpha,17alpha,20S,23R,24R)-21,24-epoxy-23,25-dihydroxy-4,8,8-trimethyl-3-oxocholesta-1,14-dien-7-yl benzeneacetic acid ester|turrapubesol B

Lys Asn Lys Glu Ser

C24H44N8O10 (604.3180244)

Gly Leu Arg Val Phe

C29H48N8O6 (604.3696628)

Ile Thr Ser Arg Glu

C24H44N8O10 (604.3180244)

Arg Thr Leu Ser Asp

C24H44N8O10 (604.3180244)

Ile Val Ile Phe Asn

C30H48N6O7 (604.3584298)

Glu Ile Asp Thr Lys

C25H44N6O11 (604.3067914)

C33H48O10_(2alpha,5alpha,9alpha,10beta,14beta)-2,5,9,10-Tetraacetoxytaxa-4(20),11-dien-14-yl 2-methylbutanoate

NCGC00386007-01_C33H48O10_(2alpha,5alpha,9alpha,10beta,14beta)-2,5,9,10-Tetraacetoxytaxa-4(20),11-dien-14-yl 2-methylbutanoate

Phe Ile Tyr Tyr

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

Phe Leu Tyr Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

Phe Pro Arg Trp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanoic acid

Phe Pro Trp Arg

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoic acid

Phe Arg Pro Trp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-(1H-indol-3-yl)propanoic acid

Phe Arg Trp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carboxylic acid

Phe Trp Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

Phe Trp Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

Phe Tyr Ile Tyr

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

Phe Tyr Leu Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

Phe Tyr Tyr Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanoic acid

Phe Tyr Tyr Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanoic acid

His His Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C24H40N14O5 (604.330595)

His Arg His Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoic acid

C24H40N14O5 (604.330595)

His Arg Arg His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C24H40N14O5 (604.330595)

Ile Phe Tyr Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanoic acid